(19)
(11) EP 4 531 828 A1

(12)

(43) Date of publication:
09.04.2025 Bulletin 2025/15

(21) Application number: 23816494.1

(22) Date of filing: 25.05.2023
(51) International Patent Classification (IPC): 
A61K 31/155(2006.01)
A61K 9/24(2006.01)
 A61K 31/7048(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/209; A61K 31/7048; A61K 31/155; A61K 9/2054
 
C-Sets:
  1. A61K 31/155, A61K 2300/00;
  2. A61K 31/7048, A61K 2300/00;
(86) International application number:
PCT/TR2023/050469
(87) International publication number:
WO 2023/234899 (07.12.2023 Gazette 2023/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 31.05.2022 TR 202208870

(71) Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Istanbul (TR)

(72) Inventors:
  • SUNEL, Fatih
    34460 Sar yer/Istanbul (TR)
  • PEHLIVAN AKALIN, Nur
    34460 Sar yer/Istanbul (TR)
  • ARMUT, Merve
    34460 Sar yer/Istanbul (TR)
  • GULER, Tolga
    34460 Sar yer/Istanbul (TR)

(74) Representative: Genç Ilhan, Oznur 
Istanbul Patent A.S. Plaza 33, Buyukdere Cad. No: 33/16 Sisli
34381 Istanbul
34381 Istanbul (TR)

   


(54) A BILAYER TABLET FORMULATION COMPRISING EMPAGLIFLOZIN AND METFORMIN